WLA-26846-00028
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-17
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Good · Site: PainFree text: Pregnant - 36 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-19
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-22
- 2021-04-07
- 2021-07-07
- 2022-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Pregnant - 36 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Exposure during pregnancy | ○ | ○ | ○ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release